Qureight has appointed Rebecca Simmons as chief operating officer, strengthening the company’s leadership team to support sustainable growth and operational scaling as its AI-powered CT imaging biomarkers and clinical data management platform gains adoption in lung and heart disease trials.

Based in Cambridge, Simmons will lead global business operations, focusing on sustainable growth initiatives and operational excellence across scientific and technical functions. She brings over 20 years of operational leadership experience across medical research and deep tech companies.

Prior to joining Qureight, Simmons was chief operating officer at quantum computing company Riverlane, where she scaled operations from ten to 100 employees over five years and played a key role in Series A, B and C funding rounds, raising more than £100 million in venture capital. She also supported business development activities, securing over £20 million in government grants and contracts. Earlier, she co-founded and served as deputy director of THIS Institute (The Healthcare Improvement Studies Institute), building strategic partnerships with NHS stakeholders, and held advisory roles at the Danish Diabetes and Endocrine Academy.

Muhunthan Thillai, co-founder and chief executive officer of Qureight, said: “Rebecca’s experience, expertise and people-centric leadership approach will be instrumental in supporting the team as we scale the company, accelerating our mission to advance the understanding of lung and heart disease. Her blend of rigorous academic training with commercial acumen made Rebecca the natural choice to lead this next chapter of growth for Qureight. Welcome to the team, Rebecca.”

Simmons added: “Qureight’s pioneering AI-powered CT imaging biomarkers and data management platform is enabling real insights to be drawn from complex and diverse health data, to ultimately deliver real impact for patients. The team is already incredible, with an expert team of clinicians, scientists and machine learning engineers. I’m delighted to join the company and am looking forward to an exciting year.”